Bibliographic
We examined the potential protective effect of BDNF against β-amyloid-induced neurotoxicity in vitro and in vivo in rats. In neuronal cultures, BDNF had specific and dose–response protective effects on neuronal toxicity induced by Aβ1–42 and Aβ25–35. It completely reversed the toxic action induced by Aβ1–42 and partially that induced by Aβ25–35. These effects involved TrkB receptor activation since they were inhibited by K252a. Catalytic BDNF receptors (TrkB.FL) were localized in vitro in cortical neurons (mRNA and protein). In in vivo experiments, Aβ25–35 was administered into the indusium griseum or the third ventricle and several parameters were measured 7 days later to evaluate potential Aβ25–35/BDNF interactions, i.e. local measurement of BDNF release, number of hippocampal hilar cells expressing SRIH mRNA and assessment of the corpus callosum damage (morphological examination, pyknotic nuclei counting and axon labeling with anti-MBP antibody). We conclude that BDNF possesses neuroprotective properties against toxic effects of Aβ peptides.
Therapeutic Agent
Animal Model
Experimental Design
Study Balanced for Sex: It is unclear whether in vivo studies were balanced for sex. Female rats were likely used to provide fetuses to generate neuronal cultures, while male rats were likely used in the in vivo studies.
Age of Animal: In studies using rats, typically the rat weight is reported rather than age. A male Sprague Dawley rat weighing 230-250g is between 6-8 weeks old. A female Sprague Dawley rat weighing 230-250g is between 9-11 weeks old.